Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Consulting Services RFPsConsulting Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More consulting services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Grants
  5. ›Genomic Variant Interactions With Other Variants Or The Environment…

U.S. National Institutes of Health·United States of America

Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026$1M – $1.5MGrants Notice
Get bids like this by emailBid source

Description

This NIH RFA seeks to fund up to five UM1 cooperative‑agreement research centers that will develop and apply frameworks for studying non‑additive genetic and environmental interactions affecting genomic variant impact. Awardees will generate experimental data, predictive methods, and share resources through the Impact of Genomic Variation on Function (IGVF) portal, collaborating across a national consortium. • Funding: up to $1.5 M per award (total estimated funding $10 M, 5 awards). • Activity code: UM1 (complex‑structure cooperative agreement). • Eligibility: wide range of U.S. and foreign‑eligible entities (universities, nonprofits, for‑profit, small businesses, government). • Key deliverables: research framework, experimental interaction testing, data/analysis sharing via IGVF portal, predictive method publication. • Consortium participation: monthly calls, annual meetings, shared governance (Steering Committee). • Duration: multi‑year (typical UM1 awards span 4–5 years, though not explicitly stated). • Submission window: 14 Nov 2026 – 14 Dec 2026. • Contact: IGVF Program Team (nhgri‑[email protected]) and NIH program officer Mike Pazin.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Mike Pazin

[email protected]

(301) 480-2629

Key dates

Opened
6/6/2025
Closes
12/14/2026
Projected award
5/25/2026
Duration
4 years

Last updated

Details

Type
Grants Notice
Industry
Consulting Services
NAICS
541714
Solicitation №
RFA-HG-27-009

Budget estimate

$1,000,000 – $1,500,000

The NOFO lists an estimated total funding pool of $10 M and an award ceiling of $1.5 M per award, with five awards planned. Assuming competitive distribution, individual award amounts are likely to fall between $1 M and $1.5 M. The final amount will depend on the scope of the proposed research framework, the scale of experimental work, and the level of data‑resource contributions required.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 95%

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. National Institutes of Health·United States of America

93% match

Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)

Closes 12/14/2026Opened 6/6/2025

U.S. National Institutes of Health·United States of America

86% match

IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. National Institutes of Health·United States of America

85% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

84% match

Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/30/2024

U.S. National Institutes of Health·United States of America

83% match

Genomic Community Resources (U24 Clinical Trials Not Allowed)

Closes 1/24/2027Opened 2/9/2026

U.S. National Institutes of Health·United States of America

83% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

82% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

81% match

Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

Closes 10/8/2027Opened 12/18/2024

U.S. National Institutes of Health·United States of America

81% match

Research on the Ethical, Legal and Social Implications (ELSI) of Genomics

Closes 2/15/2027Opened 6/3/2026

U.S. National Institutes of Health·United States of America

81% match

Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)

Closes 2/26/2027Opened 12/16/2024

U.S. National Institutes of Health·United States of America

81% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024

U.S. National Institutes of Health·United States of America

81% match

GREGoRi Innovation Projects (U01 Clinical Trial Optional)

Closes 10/30/2026Opened 6/10/2025

U.S. National Institutes of Health·United States of America

80% match

Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

Closes 11/10/2026Opened 12/29/2025

U.S. National Institutes of Health·United States of America

80% match

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

Closes 11/5/2026Opened 9/26/2023

U.S. National Institutes of Health·United States of America

80% match

Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

Closes 1/11/2027Opened 1/20/2026

U.S. National Institutes of Health·United States of America

80% match

NIH Brain Development Cohorts (NBDC) and�Population Assessment of Tobacco and Health (PATH) Study�Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 4/17/2029Opened 9/10/2025

U.S. National Institutes of Health·United States of America

80% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024

U.S. National Institutes of Health·United States of America

80% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

79% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

79% match

Opportunities for Collaborative Research with the NIH Intramural Research Program (U01 Clinical Trial Optional)

Closes 2/4/2027Opened 7/16/2026

U.S. National Institutes of Health·United States of America

79% match

Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)

Closes 3/6/2027Opened 6/17/2025

U.S. National Institutes of Health·United States of America

79% match

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)

Closes 11/18/2026Opened 10/30/2023

U.S. National Institutes of Health·United States of America

79% match

RNomics Technology Enhancement Centers

Closes 1/31/2027Opened 8/5/2026

U.S. National Institutes of Health·United States of America

79% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026